IL6 and cancer: Dysregulated miR-197 in various cancers received sophisticated regulatory [18]: IL-6 appeared to stimulate and increase the levels of p-SATA3 and STAT3 protein, which inhibited the expression of miR-197 and thus contributed to oncogenesis via promoting cell proliferation, preventing apoptosis [67].